Growth hormone deficiency and the transition from pediatric to adult care
Objective: To discuss the approach to patients diagnosed with growth hormone deficiency (GHD) in childhood during the transition period from puberty to adulthood, focusing on the following: (1) physiology; (2) effects of recombinant human GH (rhGH) interruption/reinstitution after adult height achie...
Guardado en:
Autores principales: | , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/62473a5645c9445fbe71aff35c1e8087 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:62473a5645c9445fbe71aff35c1e8087 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:62473a5645c9445fbe71aff35c1e80872021-11-06T04:13:17ZGrowth hormone deficiency and the transition from pediatric to adult care0021-755710.1016/j.jped.2021.02.007https://doaj.org/article/62473a5645c9445fbe71aff35c1e80872021-11-01T00:00:00Zhttp://www.sciencedirect.com/science/article/pii/S0021755721000541https://doaj.org/toc/0021-7557Objective: To discuss the approach to patients diagnosed with growth hormone deficiency (GHD) in childhood during the transition period from puberty to adulthood, focusing on the following: (1) physiology; (2) effects of recombinant human GH (rhGH) interruption/reinstitution after adult height achievement; (3) re-evaluation of somatrotropic axis; (4) management of rhGH reinstitution, when necessary. Source of data: Narrative review of the literature published at PubMed/MEDLINE until September 2020 including original and review articles, systematic reviews and meta-analyses. Synthesis of data: Growth hormone is crucial for the attainment of normal growth and for adequate somatic development, which does not end concomitantly with linear growth. Retesting adolescents who already meet the criteria that predict adult GHD with high specificity is not necessary. Patients with isolated GHD have a high likelihood of normal response to GH testing after puberty. Adolescents with confirmed GHD upon retesting should restart rhGH replacement and be monitored according to IGF-I levels, clinical parameters, and complementary exams. Conclusion: Patients with isolated idiopathic GHD in childhood are a special group who must be reevaluated for GHD as many of them have normal GH provocative tests upon retesting after puberty. Patients who confirm the persistence of GHD in the transition period should maintain rhGH replacement in order to reach an ideal peak bone mass, satisfactory body composition, lipid and glucose profiles, and quality of life.Ana Beatriz Winter TavaresPaulo Ferrez Collett-SolbergElsevierarticleGrowth hormoneHypopituitarismAdolescentMetabolismGrowth and developmentTherapeuticsPediatricsRJ1-570ENJornal de Pediatria, Vol 97, Iss 6, Pp 595-602 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Growth hormone Hypopituitarism Adolescent Metabolism Growth and development Therapeutics Pediatrics RJ1-570 |
spellingShingle |
Growth hormone Hypopituitarism Adolescent Metabolism Growth and development Therapeutics Pediatrics RJ1-570 Ana Beatriz Winter Tavares Paulo Ferrez Collett-Solberg Growth hormone deficiency and the transition from pediatric to adult care |
description |
Objective: To discuss the approach to patients diagnosed with growth hormone deficiency (GHD) in childhood during the transition period from puberty to adulthood, focusing on the following: (1) physiology; (2) effects of recombinant human GH (rhGH) interruption/reinstitution after adult height achievement; (3) re-evaluation of somatrotropic axis; (4) management of rhGH reinstitution, when necessary. Source of data: Narrative review of the literature published at PubMed/MEDLINE until September 2020 including original and review articles, systematic reviews and meta-analyses. Synthesis of data: Growth hormone is crucial for the attainment of normal growth and for adequate somatic development, which does not end concomitantly with linear growth. Retesting adolescents who already meet the criteria that predict adult GHD with high specificity is not necessary. Patients with isolated GHD have a high likelihood of normal response to GH testing after puberty. Adolescents with confirmed GHD upon retesting should restart rhGH replacement and be monitored according to IGF-I levels, clinical parameters, and complementary exams. Conclusion: Patients with isolated idiopathic GHD in childhood are a special group who must be reevaluated for GHD as many of them have normal GH provocative tests upon retesting after puberty. Patients who confirm the persistence of GHD in the transition period should maintain rhGH replacement in order to reach an ideal peak bone mass, satisfactory body composition, lipid and glucose profiles, and quality of life. |
format |
article |
author |
Ana Beatriz Winter Tavares Paulo Ferrez Collett-Solberg |
author_facet |
Ana Beatriz Winter Tavares Paulo Ferrez Collett-Solberg |
author_sort |
Ana Beatriz Winter Tavares |
title |
Growth hormone deficiency and the transition from pediatric to adult care |
title_short |
Growth hormone deficiency and the transition from pediatric to adult care |
title_full |
Growth hormone deficiency and the transition from pediatric to adult care |
title_fullStr |
Growth hormone deficiency and the transition from pediatric to adult care |
title_full_unstemmed |
Growth hormone deficiency and the transition from pediatric to adult care |
title_sort |
growth hormone deficiency and the transition from pediatric to adult care |
publisher |
Elsevier |
publishDate |
2021 |
url |
https://doaj.org/article/62473a5645c9445fbe71aff35c1e8087 |
work_keys_str_mv |
AT anabeatrizwintertavares growthhormonedeficiencyandthetransitionfrompediatrictoadultcare AT pauloferrezcollettsolberg growthhormonedeficiencyandthetransitionfrompediatrictoadultcare |
_version_ |
1718443919582167040 |